Trials / Completed
CompletedNCT05428384
Validation of CardioMEMS HF System Cardiac Output Algorithm IDE
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 89 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigation will enroll subjects who have been previously implanted with the CardioMEMS™ Pulmonary Artery Sensor. This clinical investigation is twofold; in the first phase (development phase) data collected will be used to complete development of an algorithm that can estimate cardiac output from CardioMEMS™ Heart Failure (HF) System readings. The second phase (validation phase) of this clinical investigation is intended to compare the Cardiac Output estimate from CardioMEMS HF System to Cardiac Output estimates from Cardiac Magnetic Resonance Imaging (reference standard).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MRI/ CardioMEMS comparison | Each subject will have CardioMEMS readings paired with MRI scans |
Timeline
- Start date
- 2022-08-31
- Primary completion
- 2024-01-30
- Completion
- 2024-01-30
- First posted
- 2022-06-23
- Last updated
- 2025-05-23
Locations
8 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05428384. Inclusion in this directory is not an endorsement.